Detalhe da pesquisa
1.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials.
Haematologica
; 109(1): 245-255, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439329
2.
Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre study.
Ann Hematol
; 103(1): 1-4, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37940717
3.
Efficacy of Helicobater pylori eradication in patients with diffuse large B-cell lymphoma of the stomach: A systematic review.
Eur J Haematol
; 109(6): 643-647, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175387
4.
Autologous stem cell transplantation in multiple myeloma patients over 70 years: A GIMEMA Lazio Working Group experience in a retrospective case-control study.
Eur J Haematol
; 109(3): 250-256, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35617025
5.
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Blood
; 134(10): 798-801, 2019 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292118
6.
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases.
Eur J Haematol
; 106(4): 493-499, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33378569
7.
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".
Eur J Haematol
; 105(3): 335-343, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441419
8.
Response to "Conditioning with melphalan (Mel) 200 mg/m2 and subsequent autologous stem cell transplantation improves progression free survival and overall survival in elderly multiple myeloma patients compared to standard of care".
Eur J Haematol
; 110(2): 221, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300853
9.
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
Eur J Haematol
; 2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719938
10.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
Eur J Haematol
; 96(6): 643-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26277477
11.
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
Am J Hematol
; 91(3): 318-21, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748894
12.
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials.
Am J Hematol
; 96(8): E269-E272, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33878220
13.
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.
Am J Hematol
; 96(8): E306-E310, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989438
14.
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study.
Am J Hematol
; 96(5): E168-E171, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580969
15.
A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms.
Ann Hematol
; 93(4): 609-16, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24173087
16.
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients.
Am J Hematol
; 89(5): 542-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24481665
17.
Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
Blood Adv
; 8(6): 1529-1540, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231017
18.
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
Br J Haematol
; 160(5): 673-9, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23240810
19.
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.
Eur J Haematol
; 2018 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30039576
20.
Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach.
EJHaem
; 4(1): 266-268, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36819169